BioSpace News Archive

Kite, a Gilead Company, announced the U.S. Food and Drug Administration has approved Yescarta® CAR T-cell therapy for adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or that relapses within 12 months of first-line chemoimmunotherapy.

Siena, 1April 2022 - Philogen S.p.A., a clinical-stage biotechnology company focused on antibody- and small molecule-based targeted therapeutics, provides an update regarding the Company’s full year 2021 results and recent corporate developments.

ADMA Biologics, Inc. announced a poster presentation and exclusive Key Opinion Leader symposium by nationally recognized clinical experts on the management of respiratory viral infections and real-world experience with ADMA’s ASCENIV, a U.S. Food and Drug Administration -approved intravenous immunoglobulin product with a unique composition.

Anebulo Pharmaceuticals, Inc. today announced the dosing of more than half of the 60 subjects planned in Part A of an ongoing Phase 2 clinical trial at the Centre for Human Drug Research (CHDR) in the Netherlands.

Petros Pharmaceuticals, Inc. today announces financial results for the fiscal year ended December 31, 2021.

Numinus Wellness Inc. will release its financial results for the quarter ended February 28, 2022, after market close on Thursday, April 14, 2022.

Natera, Inc. announced the results of a study 1 to examine both total and donor-derived cell-free DNA (dd-cfDNA) in kidney transplant recipients hospitalized with COVID-19 using its Prospera™ test to assess disease severity and risk of rejection.

Ocugen, Inc. announced that the first patient has been dosed in the Phase 1/2 clinical trial of OCU400.

Celsion Corporation today announced the company reported a cash position of $56.9 million as of December 31, 2021 during its earnings announcement on March 31, 2022.

Foghorn ® Therapeutics Inc. today announced the company will have an oral and late-breaking poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting, taking place April 8-13, 2022, in New Orleans, Louisiana.